Inhibition by a novel anti-arrhythmic agent, NIP-142, of cloned human cardiac K+ channel Kv1.5 current

Life Sciences

Volumn 68, Issue 17, 2001, Pages 2017-2024

  Matsuda, Tomoyuki ^a,b   Masumiya, Haruko ^a   Tanaka, Naoko ^a   Yamashita, Toru ^b   Tsuruzoe, Nobutomo ^b   Tanaka, Yoshio ^a   Tanaka, Hikaru ^a   Shigenoba, Koki ^a  

^a TOHO UNIVERSITY   (Japan)

^b NISSAN CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

Atria; Atrial fibrillation; Kv1.5; NIP 142

Indexed keywords

ANTIARRHYTHMIC AGENT; NIP 142; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; CELL CLONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTRIC POTENTIAL; FREQUENCY MODULATION; HEART; HUMAN; HUMAN CELL; IC 50; NUCLEOTIDE SEQUENCE; POTASSIUM CURRENT;

ANTI-ARRHYTHMIA AGENTS; BENZOPYRANS; CELL LINE; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INHIBITORY CONCENTRATION 50; MEMBRANE POTENTIALS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS;

EID: 0035896260     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01003-7     Document Type: Article

References (30)

1. Dofetilide, a new class III antiarrhythmic agent
2. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone atrial fibrillation trial investigators
3. Comparison of the safety and efficacy of flecainide versus propafenone in hospital outpatients with symptomatic parocysmal atrial fibrillation/flutter. The flecainide af French study group
4. A novel benzopyran derivative NIP-142 has unique atrium- sinus-selective antiarrhythmic effects in vitro
5. + current in adult rat atrial myocytes
6. Cardiac ultrarapid delayed rectifiers: A novel potassium current family of functional similarity and molecular diversity
7. Sustained depolarization induced outward current in human atrial myocytes: Evidence for a novel delayed rectifier potassium current similar to Kv1.5 cloned channel currents
8. Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization
9. + channel protein in explanted cardiac tissue
10. Effects of propafenone on K currents in human atrial myocytes
11. Effects of flecainaide, quinidine, and 4-aminipyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes
12. Gating charge and ionic currents associated with quinidine block of human Kv1.5 delayed rectifier channels
13. Effects of propafenone and 5-hydrocy-propafenone on hKv1.5 channels
14. Inhibition of cloned human cardiac Kv1.5 potassium channel current by novel antiarrhythmic agent, NIP-142
15. + channel cDNAs from human ventricle
16. Closed- and open-state binding of 4-aminopyridine to the cloned human potassium channel Kv1.5
17. Evidence for multiple open and inactivated states of the hKv1.5 delayed rectifier
18. + channel current
19. Interactions of the nonsedating antihistamine loratadine with a Kv1.5-type potassium channel cloned from human heart
20. Time-, voltage-, state-dependent block by quinidine of a cloned human cardiac channel
21. Class III antiarrhythmic effects of zatebradine: Time-, state-, use-, and voltage-dependent block of hKv1.5 channels
22. Block of human cardiac Kv1.5 channels by loratadine: Voltage-, time- and use-dependent block at concentrations above therapeutic levels
23. + channel Kv1.5 by the antibiotic erythromycin
24. The molecular ionic specificity of antiarrhythmic drug actions
25. + current in human ventricular myocytes
26. Dose-dependence of 4-aminopyridine plasma concentrations and electrophysiological effects in dogs: Potential relevance to ionic mechanisms in vivo